Application no. and date | 15150984.1 (espacenet) (Federated) (European Patent Register), 20050708 | Patent/reg. no. and date | DK/EP 2921500, 20230830 | Publication date | 20150923 | Priority no. and date | US 586581 P, 20040710 | EP pub. no. and date |
EP 2921500 20150923 | Effective date | | Applicant/owner | The Institute for Cancer Research, 333 Cottman Avenue
Philadelphia PA 19111, US | Applicant ref. no. | V2309-003-DK | Inventor | Cambell, Kerry S., 2 Hemlock Lane
Wyncote, PA 19095, US | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 35/12 (2015.01) , A61P 31/00 (2006.01) , A61P 35/00 (2006.01) , C07K 14/735 (2006.01) , C07K 16/28 (2006.01) , C07K 16/32 (2006.01) , C12N 5/0783 (2010.01) , G01N 33/50 (2006.01) | Title | GENETISK MODIFICEREDE, HUMANE, NATURLIGE DRÆBERCELLELINJER | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Rettet DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|